Find Federal Grants
Development of Alternative Human Models of Radiation-Induced Injuries (Extracorporeal Systems) (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-24-067
Health Resources and Services Administration · HRSA-25-028
Health Resources and Services Administration · HRSA-25-018
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional)
National Institutes of Health · PAR-25-050
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)
National Institutes of Health · PAR-25-055
Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)
National Institutes of Health · PAR-25-020
Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required)
National Institutes of Health · RFA-CA-25-010
Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT)- Lung Cancer Screening (UG3/UH3 Clinical Trial Required)
National Institutes of Health · RFA-CA-25-009
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
National Institutes of Health · PA-25-080
Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)
National Institutes of Health · RFA-CA-25-013
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
National Institutes of Health · PAR-24-294
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
National Institutes of Health · PAR-24-293
Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R21 Clinical Trials Not Allowed)
National Institutes of Health · RFA-DA-26-010
Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R01 Clinical Trials Not Allowed)
National Institutes of Health · RFA-DA-26-009
National Institutes of Health · PAR-25-061
Pakistan USAID-Islamabad · 72039124RFA00002
Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center (U24 Clinical Trials Not Allowed)
National Institutes of Health · RFA-CA-24-036
Section 206 of the Consolidated Appropriations Act, 2024: State Planning Grants to Promote Continuity of Care for Medicaid and CHIP Beneficiaries Following Incarceration
Center for Medicare and Medicaid Services · CMS-2T2-25-001
National Coordinating Center (NCC) for AHRQs Healthcare Extension Service - State-based Solutions to Healthcare Improvement (U54)
Agency for Health Care Research and Quality · RFA-HS-24-006
National Evaluation Center (NEC) for AHRQs Healthcare Extension Service: State-based Solutions to Healthcare Improvement (U19)
Agency for Health Care Research and Quality · RFA-HS-24-005